Cohere-Med Inc.

Cohere-Med demonstrates strong theoretical real-world utility as a health-tech spin-off utilizing predictive analytics for acute care. However, the submission contains vague and highly exaggerated claims ('everyone' as target audience, 'most people have used my product'), which contradict its nature as specialized B2B clinical software. The lack of verifiable active user metrics, combined with poor response quality, heavily penalizes the evidence of traction and audience reach scores, placing the project firmly in the minimal traction category.